The question is whether his bet will be validated by future trials in healthy, non-obese adults
Monthly pricing remains flat regardless of dose adjustments, so as your treatment progresses and your dose increases, your out-of-pocket expense stays predictable
GLP-1 agonists were originally designed to treat type 2 diabetes by triggering the release of another hormone called insulin into the bloodstream, which lowers blood sugar levels
The trial, funded by Novo Nordisk, the manufacturer of Wegovy (semaglutide), found the drug improved liver inflammation, scarring (fibrosis), and sometimes both in people with metabolic dysfunction-associated steatohepatitis (MASH)
While many competitors build their models around complex intake schedules, restrictive meal protocols, or tech-heavy tracking apps, Clinic Secret adopts a model that's frictionless and intuitive
JafariSGuercettiJGeballa-KoukoulaATsagkarisASNelisJLDMarcoMPet al